Application of the area under the curve of carboplatin in predicting toxicity and efficacy
- 1 December 1998
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 24 (6) , 407-414
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Normalisation of anti-cancer drug dosage using body weight and surface area: is it worthwhile?Cancer Chemotherapy and Pharmacology, 1993
- Clinical Pharmacokinetics of CarboplatinClinical Pharmacokinetics, 1991
- Is Dose Normalization to Weight or Body Surface Area Useful in Adults?JNCI: Journal of the National Cancer Institute, 1990
- More is better.Journal of Clinical Oncology, 1988
- Quantitative estimation of cisplatin-induced DNA interstrand cross-links and their repair in mammalian cells: Relationship to toxicityPharmacology & Therapeutics, 1987
- The formation, isolation and characterization of DNA adducts produced by anticancer platinum complexesPharmacology & Therapeutics, 1987
- Dose-response is alive and well.Journal of Clinical Oncology, 1986
- Ovarian trials at the Royal MarsdenCancer Treatment Reviews, 1985
- Preclinical studies identifying carboplatin as a viable cisplatin alternativeCancer Treatment Reviews, 1985
- Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum IICancer Chemotherapy and Pharmacology, 1982